Original Article

CME Article: Utility of the Montreal Cognitive Assessment as a Screening Test for Neurocognitive Dysfunction in Adults with Sickle Cell Disease

Objectives: Neurocognitive dysfunction is an important complication of sickle cell disease (SCD), but little is published on the utility of screening tests for cognitive impairment in people with the disease. The purpose of this study was to evaluate the Montreal Cognitive Assessment (MoCA) as a screening tool and identify predictors…

Posted in: cognitive impairment 2 screening 33 sickle cell disease 28

Review Article

Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment

Abstract:Complaints of loss of memory and lack of concentration have been reported by long-term survivors of breast cancer. This mild cognitive impairment (MCI), also called “chemobrain” or “chemofog,” has been the subject of a number of studies in the last few years. This cognitive impairment, although usually mild, must be…

Posted in: breast cancer 44 cognitive impairment 2
SMA Menu